TP53 and breast cancer: However IGFBP-3 was downregulated following treatment with DNA-damaging agents in a subset of breast cancer cells that also contain p53 mutations: MDA-MB-231 (R280K), MDA-MB-436 (E204Fs) and MDA-MB-468 (R273H).